Pulmonary infection by Lophomonas spp. and Aspergillus spp. in a B-cell acute lymphocytic leukemia patient from Chile

Isabel Iturrieta-González1, Enzo Moenen-Locoz2, Alejandro Hidalgo3

  • 1Department of Preclinic Sciences, Medicine Faculty, Laboratory of Infectology and Clinical Immunology, Center of Excellence in Translational Medicine-Scientific and Technological Nucleus (CEMT-BIOREN), Universidad de La Frontera, Temuco 4810296, Chile; Jeffrey Modell Center of Diagnosis and Research in Primary Immunodeficiencies, Center of Excellence in Translational Medicine, Medicine Faculty, Universidad de La Frontera, Temuco 4810296, Chile.

Parasitology International
|September 19, 2024
PubMed

Insights

Lophomoniasis, a rare parasitic lung infection, was diagnosed in an immunocompromised patient. Prompt identification and treatment with metronidazole led to a favorable outcome, highlighting the need for awareness in respiratory samples.

Area of Science:

  • Medical Parasitology
  • Infectious Diseases
  • Clinical Microbiology

Background:

  • Lophomonas spp. are flagellated protozoa, typically commensals in arthropods and birds.
  • Lophomoniasis is a rare human infection, primarily affecting the lungs in immunocompromised individuals.
  • Transmission occurs via airborne or ingested cystic forms, posing a risk to vulnerable populations.

Observation:

  • A 50-year-old patient with B-cell acute lymphocytic leukemia presented with pulmonary symptoms.
  • Radiological and laboratory findings suggested pulmonary infection, initially suspected as aspergillosis.
  • Microscopic examination of Bronchoalveolar Lavage (BAL) revealed Lophomonas spp. trophozoites.

Findings:

  • The case presented a dual diagnosis of lophomoniasis and probable pulmonary aspergillosis.
  • Lophomoniasis was treated with metronidazole, while pulmonary aspergillosis required a combination antifungal regimen.
  • The patient showed a positive response to treatment and was discharged after 95 days.

Implications:

  • This case underscores the importance of identifying Lophomonas spp. in respiratory samples from immunocompromised patients with pulmonary symptoms.
  • Recognizing lophomoniasis is crucial, especially in cases unresponsive to standard antimicrobial therapies.
  • Further research is needed to elucidate Lophomonas spp. sources and develop effective prevention strategies for high-risk individuals.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
213
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
312
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
214
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
903
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
224